Skip to main content
. Author manuscript; available in PMC: 2009 Jun 23.
Published in final edited form as: Dig Dis Sci. 1998 Feb;43(2):311–316. doi: 10.1023/a:1018898120673

Fig 1.

Fig 1

Prostaglandin levels (ng/mg protein) in colorectal mucosa. PGD2, prostaglandin D2; PGE2, prostaglandin E2; PGF, prostaglandin F; TXB2, thromboxane B2; 6-keto-F1, 6-keto-prostaglandin F. FAP patients 1–4 are noted. * P = 0.016 control vs FAP; ** P < 0.05 FAP vs FAP and sulindac; P < 0.05 control vs FAP and sulindac. Controls are five otherwise healthy Caucasians with normal colonoscopic examinations. FAP patients are four Caucasian patients with previous colectomy and ileorectal anastomosis. Patient 4 developed colorectal cancer after 35 months of sulindac treatment.